Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our intimated details dated September 15, 2021 and Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we submit herewith a copy of advertisement published today i.e. September 16, 2021 as a public notice in Free Press Journal and Navshakti newspapers, regarding Corrigendum to the Notice of 36th AGM. BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the following shareholder. BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on September 06, 2021 has approved the allotment of 1,51,750 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019'). Bliss GVS Pharma Ltd - 506197 - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year Ended March 31, 2021
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and in continuation to our intimated details on July 31, 2021 relating to Book Closure, please note that Bliss GVS Pharma Limited ('the Company') has fixed Tuesday, September 14, 2021 as the Record Date for determining entitlement of members to Final Dividend for the financial year ended on March 31, 2021. Payment of Dividend, subject to approval of the members at the ensuing AGM, will be made on or after Wednesday, September 22, 2021. BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements pertaining to Notice of 36th Annual General Meeting of the Company scheduled to be held on Tuesday, September 21, 2021 at 11:00 a.m. (IST) through Video Conferencing/Other Audio Visual Means, e-Voting details and Book Closure information. The above advertisements was published on August 30, 2021 in Free Press Journal and Navshakti newspapers. BLISS GVS PHARMA LTD. - 506197 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed Notice convening the 36th AGM and the Annual Report of the Company for the financial year 2020-21. The Notice convening the 36th AGM and the Annual Report of the Company for the financial year 2020-21 has been sent to all the members of the Company whose email addresses are registered with the Company/Registrar and Share Transfer Agent/ Depository Participant(s), in compliance with relevant circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India. The Annual Report for the financial year 2020-21 is also being made available on the website of the Company. Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of advertisement of public notice issued in respect of information regarding 36th Annual General Meeting of the Company scheduled to be held on Tuesday, September 21, 2021 at 11:00 a.m. (IST) through Video Conferencing ('VC")/Other Audio Visual Means ('OAVM'), in compliance with the General Circulars dated April 08, 2020, April 13, 2020, May 05, 2020 and January 13, 2021 issued by the Ministry of Corporate Affairs ('MCA Circulars') along with the Circular issued by Securities and Exchange Board of India ('SEBI Circular') dated May 12, 2020 and January 15, 2021 published in Free Press Journal and Navshakti - Mumbai newspapers on August 22, 2020. BLISS GVS PHARMA LTD. - 506197 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Of Russian Good Manufacturing Practice ('GMP') Approval
We wish to inform you that the Company has received the Russian GMP Certificate for manufacturing unit situated at Plot no. 11, Survey no. 38/1, Dewan Udyog Nagar, Aliyali Village, Tal. Dist-Palghar, 401404 from Ministry of Industry & Trade of the Russian Federation on the compliance of the manufacturer (foreign manufacturer) of medicinal products for medical use with the requirements of the Rules of Good Manufacturing Practice. BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement of Unaudited Financial Results of the Company for the quarter ended June 30, 2021 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on August 02, 2021. Kindly take the same on record.